L01EX06 · Antineoplastic and immunomodulating agents
Masitinib AB Science
Indications
In combination with riluzole for the treatment of adult patients with amyotrophic lateral sclerosis (ALS)
Composition
- Active substance
- Masitinib mesilate
- International name (INN)
- masitinib
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Masitinib AB Science
- Active substance
- Masitinib mesilate
- ATC code
- L01EX06
- Therapeutic area
- Amyotrophic Lateral Sclerosis
- Marketing authorisation holder
- AB Science
- Status